BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  Intradigm Corporation Raises $18.5 Million in Series B Financing

  October 2, 2008

   · 

  3 min read
• FDA

  FDA Approves Use of Bristol-Myers Squibb Company’s REYATAZ(R) Boosted with Ritonavir, in Combination Therapy, for Previously Untreated HIV-1 Infected Adult Patients

  October 2, 2008

   · 

  4 min read
• Drug Development

  Crucell N.V. Announces Positive Results of Phase II Clinical Study Rabies Monoclonal Antibody Combination in US

  October 2, 2008

   · 

  6 min read
• Pharm Country

  DxTech Receives Development Funding

  October 2, 2008

   · 

  1 min read
• Biotech Bay

  Sadra Medical Announces Patient Enrollment in European Feasibility Study of the Lotus™ Valve System

  October 2, 2008

   · 

  1 min read
• Pharm Country

  Transave, Inc. Secures $12.5 Million in New Financing

  October 2, 2008

   · 

  6 min read
• Business

  Genesis Pharmaceutical, Inc. Reports Results for its Fourth Quarter and Fiscal Year 2008

  October 2, 2008

   · 

  9 min read
• Pharm Country

  Delcath Systems, Inc. To Present At The Maxim Group Growth Conference

  October 2, 2008

   · 

  1 min read
• Drug Development

  Access Pharmaceuticals Presents New Data on the Company’s Angiolix(R) Therapeutic Monoclonal Antibody Data Indicate Dual Modes of Action and Synergy with Chemotherapy

  October 2, 2008

   · 

  3 min read
• Business

  Cubist Pharmaceuticals, Inc. to Announce Third Quarter 2008 Financial Results on Thursday, October 16, 2008

  October 2, 2008

   · 

  1 min read